These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 32625487)
61. Safety of egg membrane hydrolysate as a novel food pursuant to Regulation (EU) 2015/2283. ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Schlatter JR; Ackerl R; van Loveren H EFSA J; 2018 Jul; 16(7):e05363. PubMed ID: 32625994 [TBL] [Abstract][Full Text] [Related]
62. Soy- and rice-based formula and infant allergic to cow's milk. Tzifi F; Grammeniatis V; Papadopoulos M Endocr Metab Immune Disord Drug Targets; 2014 Mar; 14(1):38-46. PubMed ID: 24450453 [TBL] [Abstract][Full Text] [Related]
63. Effects of Cow's Milk Components, Goat's Milk and Sheep's Milk Sensitivities on Clinical Findings, and Tolerance Development in Cow's Milk Allergy. Gunaydin NC; Severcan EU; Akarcan SE; Bal CM; Gulen F; Tanac R; Demir E Sisli Etfal Hastan Tip Bul; 2021; 55(3):391-397. PubMed ID: 34712082 [TBL] [Abstract][Full Text] [Related]
64. Safety of the extension of use of 2'-fucosyllactose/difucosyllactose (2'-FL/DFL) mixture and lacto- ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Prieto Maradona M; Schlatter JR; van Loveren H; Colombo P; Noriega Fernández E; Knutsen HK EFSA J; 2022 Mar; 20(3):e07140. PubMed ID: 35281646 [TBL] [Abstract][Full Text] [Related]
65. Hypoallergenic formulas--when, to whom and how long: after more than 15 years we know the right indication! Høst A; Halken S Allergy; 2004 Aug; 59 Suppl 78():45-52. PubMed ID: 15245358 [TBL] [Abstract][Full Text] [Related]
66. Evaluation of the buffering capacity of powdered cow's, goat's and soy milk and non-prescription antacids in the treatment of non-ulcer dyspepsia. Lutchman D; Pillay S; Naidoo R; Shangase N; Nayak R; Rughoobeer A S Afr Med J; 2006 Jan; 96(1):57-61. PubMed ID: 16440114 [TBL] [Abstract][Full Text] [Related]
67. Use of prick-tests in the screening of immediate allergy to protein: 16 cases. Rancé F; Brondeau V; Abbal M Allerg Immunol (Paris); 2002 Mar; 34(3):71-6. PubMed ID: 12012790 [TBL] [Abstract][Full Text] [Related]
68. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
69. Safety of 2'-fucosyllactose (2'-FL) produced by a derivative strain (APC199) of ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Prieto Maradona M; Schlatter JR; van Loveren H; Colombo P; Noriega Fernández E; Knutsen HK EFSA J; 2022 Dec; 20(12):e07647. PubMed ID: 36531695 [TBL] [Abstract][Full Text] [Related]
70. Guidance on the preparation and presentation of applications for exemption from mandatory labelling of food allergens and/or products thereof pursuant to Article 21 (2) of Regulation (EU) No 1169/2011. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) EFSA J; 2021 Mar; 19(3):e06543. PubMed ID: 33791035 [TBL] [Abstract][Full Text] [Related]
71. Chromium content in different kinds of Spanish infant formulae and estimation of dietary intake by infants fed on reconstituted powder formulae. Sola-Larrañaga C; Navarro-Blasco I Food Addit Contam; 2006 Nov; 23(11):1157-68. PubMed ID: 17071518 [TBL] [Abstract][Full Text] [Related]
72. Allergy to soy formula and to extensively hydrolyzed whey formula in infants with cow's milk allergy: a prospective, randomized study with a follow-up to the age of 2 years. Klemola T; Vanto T; Juntunen-Backman K; Kalimo K; Korpela R; Varjonen E J Pediatr; 2002 Feb; 140(2):219-24. PubMed ID: 11865274 [TBL] [Abstract][Full Text] [Related]
73. Hydrolyzed rice formula for dietary management of infants with cow's milk allergy. Fiocchi A; Barrio-Torres J; Dupont C; Howells HE; Shamir R; Venter C; Meyer R World Allergy Organ J; 2022 Dec; 15(12):100717. PubMed ID: 36438193 [TBL] [Abstract][Full Text] [Related]
74. Acute allergic skin response as a new tool to evaluate the allergenicity of whey hydrolysates in a mouse model of orally induced cow's milk allergy. van Esch BC; Schouten B; Hofman GA; van Baalen T; Nijkamp FP; Knippels LM; Willemsen LE; Garssen J Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 2):e780-6. PubMed ID: 19563464 [TBL] [Abstract][Full Text] [Related]
75. Food intake and growth of infants between six and twenty-six weeks of age on breast milk, cow's milk formula, or soy formula. Köhler L; Meeuwisse G; Mortensson W Acta Paediatr Scand; 1984 Jan; 73(1):40-8. PubMed ID: 6702448 [TBL] [Abstract][Full Text] [Related]
76. Safety of the extension of use of galacto-oligosaccharides (GOS) as a novel food in food for special medical purposes pursuant to Regulation (EU) 2015/2283. ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Prieto Maradona M; Schlatter JR; van Loveren H; Colombo P; Knutsen HK EFSA J; 2022 Mar; 20(3):e07203. PubMed ID: 35386574 [TBL] [Abstract][Full Text] [Related]
77. Scientific Opinion related to a notification from Lyckeby Starch AB on barley starch to be used in the manufacturing of several foods as ingredient, of the food additive modified starch and of glucose syrups pursuant to Article 21(2) of Regulation (EU) No 1169/2011 - for permanent exemption from labelling. ; Turck D; Castenmiller J; Hirsch Ernst KI; Kearney J; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Marchelli R; van Loveren H; Martínez SV; de Henauw S EFSA J; 2020 May; 18(5):e06118. PubMed ID: 37649494 [TBL] [Abstract][Full Text] [Related]
78. Safety of β-hydroxybutyrate salts as a novel food pursuant to Regulation (EU) 2015/2283. ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Prieto Maradona M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; van Loveren H; Albert O; Goumperis T; Knutsen HK EFSA J; 2022 Oct; 20(10):e07449. PubMed ID: 36254193 [TBL] [Abstract][Full Text] [Related]
79. Fluoride concentrations of milk, infant formulae, and soy-based products commercially available in Brazil. Nagata ME; Delbem AC; Kondo KY; de Castro LP; Hall KB; Percinoto C; Aguiar SM; Pessan JP J Public Health Dent; 2016 Mar; 76(2):129-35. PubMed ID: 26449642 [TBL] [Abstract][Full Text] [Related]
80. Whey predominant, whey modified infant formula with protein/energy ratio of 1.8 g/100 kcal: adequate and safe for term infants from birth to four months. Räihä NC; Fazzolari-Nesci A; Cajozzo C; Puccio G; Monestier A; Moro G; Minoli I; Haschke-Becher E; Bachmann C; Van't Hof M; Carrié Fässler AL; Haschke F J Pediatr Gastroenterol Nutr; 2002 Sep; 35(3):275-81. PubMed ID: 12352513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]